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Liver haemangioma: common and uncommon
findings and how to improve the differential
diagnosis
Abstract Haemangiomas are com-
mon focal liver lesions, generally
detected in the work-up of asymp-
tomatic patients. From the pathologi-
cal point of view, they can be
classified as small (capillary) or large,
with cavernous vascular spaces that
may show thrombosis, calcifications
and hyalinisation. The polymorphic
imaging appearance of haemangiomas
depends on their histological features
and flow pattern. The widespread use
of cross-sectional imaging has al-
lowed an increased detection rate and
a better characterisation of this benign
tumour. Recent developments of ul-
trasound (US), computed tomography
(CT) and magnetic resonance imaging
(MRI) providing high spatial and
temporal resolution, together with the
use of new contrast agents and/or
pulse sequences has broadened the
spectrum of imaging findings, con-
tributing to diagnostic refinement in
difficult cases. The scope of the pres-
ent article is to provide an overview of
the range of appearances of haema-
ngiomas, explored with recent cross-
sectional imaging modalities,
emphasising its atypical findings as
explored by temporally resolved
contrast-enhanced imaging.
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Introduction
Currently, the widespread use of modern cross-sectional
imaging methods has led to an increased fortuitous
detection of focal liver lesions in all patients, including
the asymptomatic and oncologic groups. Since imaging
techniques can now provide high spatial resolution, small
liver nodules are easily depicted, posing the problem of the
characterisation of the so-called incidental lesions. Recent
papers based on helical computed tomography (CT) or on
necropsy studies showed that liver tumours are more
frequent than it was previously accepted [1]. Among those,
the majority correspond to cysts, haemangiomas, focal
nodular hyperplasia, adenomas and pseudolesions, such as
focal fatty infiltration and focal fatty sparing [2]. It has been
demonstrated that the majority of incidental focal liver
lesions discovered during any abdominal imaging work-up
is, in fact, benign and devoided of particular clinical
significance, even in oncologic patients [3, 4].
The characterisation of benignancy, when dealing with a
focal liver lesion, assumes special importance, since it
leads to cost reduction concerning further imaging work-up
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and spares the patient from anxiety. Several factors are
implicated on the confidence level assigned to characterise
a focal liver lesion, such as their typical or atypical imaging
findings, the previous existence of an oncologic disease, de
novo appearance or modification of the imaging features as
seen on follow-up studies. Diminutive size is one of the
major constraints to achieving a proper characterisation
and even the state-of-the-art imaging techniques may fail to
provide the diagnosis in such cases, ultimately leading to
other diagnostic tests, possibly even invasive methods [5].
The scope of this paper is to review the atypical features
of liver haemangiomas and to show how to improve the
diagnostic confidence in their characterisation by using
state-of-the-art cross-sectional imaging techniques.
General considerations
Haemangiomas have an estimated prevalence of 0.4% to
20%, according to several autopsy studies. Being devoid of
malignant potential, they are, in general, fortuitously
discovered during any abdominal imaging work-up, mostly
being discovered between the fourth and fifth decades of
life [5–7]. They are multiple in more than 50% of cases and
show a clear female predilection (ratio of 2–5:1).
Pathological examination (Fig. 1a) reveals a focal tender
mass formed by multiple vascular channels limited by a
single layer of endothelial cells within a thin fibrous
stroma. In general, the blood circulation within these
tumour vessels is slow. Morphologically, it is a well-
defined lesion, possessing round or lobulated margins.
Although it may occur anywhere in the liver parenchyma, it
is more commonly seen at peripheral and sub-capsular
locations, mostly in the posterior segments of the right lobe
[5, 6, 8]. Their size usually remains stable and can vary
from a few millimetres to more than 20 cm, a feature that
has been used for its classification into small (<15 mm),
medium (15–50 mm) and large haemangiomas (>50 mm)
[6]. Large haemangiomas may give rise to complications in
4.5% to 19.7% of cases, consisting of bleeding, compres-
sive effect on adjacent structures such as the bowel and
torsion if pedunculated [6, 7, 9, 10].
Fig. 1 a–d Usual findings in
haemangiomas. a Histological
feature depicting the large vas-
cular spaces of a well-defined
non-capsulated tumour. b On
ultrasound (US), the tumour is
homogeneously hyperechoic
with lobulated contours. c On
computed tomography (CT),
centripetal, progressive en-
hancement is seen on the arterial
phase of the dynamic liver
study. d Magnetic resonance
imaging (MRI) shows a
homogeneous lesion with
intensity similar to cerebrospinal
fluid (CSF) on T2-w fatsat
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Common imaging findings
The most common sonographic pattern of haemangiomas
(Fig. 1b) consists of the demonstration of a homogeneous
hyperechoic liver nodule, with discrete posterior acoustic
enhancement, devoided of Doppler signal both on colour-
coded and spectral examination [11].
CT features (Fig. 1c) usually shows a hypodense well-
defined lesion, with an internal density similar to the
vessels. Dynamic studies performed after the administra-
tion of non-specific extracellular iodine compounds
exhibits early nodular peripheral enhancement (puddling),
since its feeding vessels originate from the hepatic artery.
Subsequent phases of liver enhancement reveal a progres-
sive slow centripetal fill-in, with iso- or even slight
hyperdensity on delayed phase as compared to the normal
liver parenchyma. This classical presentation is diagnostic
with a high level of confidence [5, 6]. Late intra-tumoural
accumulation of contrast can be explained by the slow
flowing blood within its vascular channels determining
iso-/hyperdensity and absence of noticeable washout on the
latter phases of the dynamic study [5, 7, 12, 13]. However,
delayed homogeneity due to complete contrast filling of the
tumour should not be regularly expected, especially for
large tumours, and, thus, should not be used as mandatory
diagnostic criteria. Small haemangiomas may appear to
enhance to a lesser extent but this may result from partial
volume averaging [5, 12].
Currently, magnetic resonance imaging (MRI) is the
imaging method of choice to diagnose haemangiomas
(Fig. 1d) [5, 6]. On T1-weighted (-w) images, haemangio-
mas display low signal intensity and on T2-w, they are
strikingly homogeneous, clearly demarcated from the
adjacent parenchyma, with very high signal intensity,
Fig. 2 a, b A case illustrating
the possibility of differentiating
non-invasively haemangiomas
from cysts using plain MRI.
Compared to the T2-w fatsat
fast spin echo (FSE) sequence
(a), the haemangioma shows a
considerable signal intensity
loss on the steady-state free
precession (SSFP) images
(TrueFISP) (b). Contrarily, bili-
ary cysts retain high signal
intensity on both sequences
Fig. 3 a–c Haemangiomas and iron-oxide enhanced MRI. a Iron-
oxide enhanced T1-w images obtained in the late retention phase.
The small haemangioma of the right liver lobe becomes hyper-
intense, which can be explained by the T1-effect exerted by the
intra-tumoural circulating iron oxide particles. Another case
showing signal intensity loss on the retention phase of the post-
contrast GRE T2-w image (b) compared to the plain T2-w fatsat
image (c)
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Fig. 4 a Isoechoic haemangio-
ma with a hyperechoic border;
this is a common atypical ap-
pearance that has been asso-
ciated with internal necrosis,
scarring or myxomatous chang-
es. b Pathological specimen of a
cavernous haemangioma with a
central area of myxomatous de-
generation (arrow). c Haeman-
gioma on a T2-w image
displaying lobulated contours
and a hyperintense central scar.
d MRI features of a giant
cavernous haemangioma; the
tumour is heterogeneous, dis-
playing internal septations,
lobulated contours and a CSF-
like signal intensity on this FSE
T2-w image
Fig. 5 a T2-w image of a
peripheral haemangioma of the
right liver lobe displaying cap-
sular retraction. Signal intensity
on the T2-w images and the
contrast enhancement pattern
(not shown) were sufficient to
warrant the diagnosis. b Coronal
volume-rendered (VR) image of
a contrast-enhanced multi-de-
tector computed tomography
(MDCT) study showing a large
pedunculated haemangioma
originating in the left liver lobe
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similar to cerebrospinal fluid (CSF), due to the long T2
relaxation time of its blood-filled vascular channels, a
feature that has been coined as the bulb-light sign [5–7, 10].
In the past, calculation of the T2 relaxation time was
deemed useful for its differential diagnosis with other focal
liver lesions, since a relaxation value of at least 112 ms
could differentiate it from metastases with a 92–97%
accuracy [5, 6, 12, 14–16]. Other MRI approaches may
include a double-echo heavily T2-w sequence [17, 18], a
fluid-attenuated inversion recovery (FLAIR) or the use of
the balanced steady-state free precession (SSFP) sequence
[19, 20], which can discriminate between haemangiomas
and simple liver cysts without the need for contrast
injection (Fig. 2). More recently, a diffusion-weighted
echo-planar technique has demonstrated usefulness in
distinguishing benign from malignant liver tumours,
based on their different magnetic properties at a micro-
scopic level [21].
The high spatial and temporal resolution provided by
state-of-the-art MRI equipment is currently used to acquire
fast gradient-echo imaging (GRE) within the time frame of
a single breath-hold, allowing contrast-enhanced dynamic
liver imaging using gadolinium chelates. Characterisation
of focal liver lesions are, thus, being progressively obtained
by the combined information conveyed by static and
dynamic imaging, with haemangiomas displaying similar
dynamic MRI features as seen on CT. Liver MRI can also
be performed with dedicated cell-specific contrast agents,
such as iron-oxide particles (SPIO), which are captured by
the Kupffer cells of the reticulo-endothelial system. Using
the most recent iron-oxide contrast agents, compatible with
a bolus-injection of small volumes, haemangiomas can
display T1-w enhancement, due to the initial extra-celular
distribution of the SPIO agent, similar to that observed with
gadolinium chelates. In the late retention phase, haema-
ngiomas can also show peculiar imaging features consist-
ing of discrete hyperintensity on T1-w images (Fig. 3a).
This is due to the slow intra-tumoural blood flow carrying
iron-oxide particles which, at very low concentrations,
produce shortening of the tumour T1 relaxation time. On
T2-w sequences, which are more prone to be disturbed by
magnetic susceptibility effects caused by the iron-oxide
particles, the haemangioma may show negative enhance-
ment and, consequently, signal loss, which may pose an
additional difficulty for its characterisation [6, 22, 23]
(Fig. 3b,c). Since haemangiomas do not contain hepa-
tocytes, enhancement should not be expected with other
specific paramagnetic contrast agents and their imaging
features are basically unremarkable when compared to
other hepatocyte-devoided liver tumours [6].
Recently, pulse-inversion ultrasound (US) after admin-
istration of the second-generation contrast agents replicates
the characteristic puddling and progressive centripetal fill-
in of haemangiomas, contributing to a diagnostic refine-
ment for undetermined cases seen on the baseline B-mode
US [24–26].
Fig. 6 a, b Asymptomatic
haemangioma causing bile duct
dilatation. a Contrast-enhanced
CT study depicting a segment
IV haemangioma. b Slice ob-
tained at an upper level reveal-
ing upstream bile duct dilatation
caused by extrinsic compres-
sion. This finding should not
preclude the diagnosis. In this
case, imaging findings remain
stable 4 years after the initial
diagnosis
Fig. 7 Plain CT of a cavernous haemangioma showing punctate
calcifications. In general, calcifications are due to intra-lesional
phlebolites but may be the end result of fibrosis and dystrophic
changes
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Uncommon presentations of haemangiomas
The diagnostic management of haemangiomas depend both
on the clinical context and the imaging features of the
tumour. In patients with a known malignancy, and with
previous normal examinations, or in cases of atypical
imaging presentation, the diagnosis needs to be confirmed
by other means beyond US, ultimately leading to the use of
invasive techniques [11]. Less typical imaging findings of
haemangiomas can result from three main causes: altered
morphology or structure, unusual flow patterns or asso-
ciated liver abnormalities. Although these aspects do not
preclude in all instances the correct diagnosis, they may be
misleading and, therefore, should be known by radiologists
in order to avoid other potentially more invasive diagnostic
tests. Whenever the diagnosis is doubtful, especially in
oncologic patients, even after a multimodality imaging
approach, a percutaneous biopsy could be sought, with
considerable evidence concerning its safety [27].
Uncommon morphology/structure
On grey-scale US, atypical haemangiomas can show an
internal iso-/hypoechoic texture with a peripheral hyper-
echoic border (Fig. 4a), which has been associated with
internal thrombosis or scarring [7]. Large haemangiomas
are frequently heterogeneous and may display a central
scar (Fig. 4b,c), which does not enhance on the late
interstitial phases of the dynamic studies. On pathology, the
scar is formed by myxomatous degeneration, thrombosis,
fibrosis or necrosis [6]. The T2-w images are frequently
unable to determine its exact composition, as seen on
pathological studies, because a central fluid-like hyper-
Fig. 8 a, b Haemorrhagic
haemangioma seen on MRI.
a T1-w FSE image disclosing an
internal hyperintense area. b On
the corresponding T2-w FSE
image, the haemorrhagic area is
hypointense, which is due to the
susceptibility effects caused by
the methaemoglobin content.
Other areas of scarring and
fibrosis are also apparent, ex-
hibiting low signal intensity on
both sequences. c T2-w fatsat
image of a haemangioma with a
fluid–fluid level. Very rarely,
haemangiomas can display an
internal fluid–fluid level traduc-
ing different blood flow veloc-
ities within the haemangioma,
with layering of red blood cells
on the dependent portion
Fig. 9 Flash-filling haemangioma on dynamic contrast-enhanced
CT showing intense homogeneous blush on the arterial phase.
Isodensity was observed on the delayed image (not shown)
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intensity can be displayed, even in cases of myxomatous
degeneration. Other atypical morphological features con-
sist of the presence of internal septations (Fig. 4d),
exhibiting low signal intensity on T1- and T2-w images
related to the presence of a fibrotic component.
Liver capsule retraction is not a frequent finding, but it
should not preclude the diagnosis, since it may be seen as
secondary to peripheral fibrotic changes (Fig. 5a) [7, 28,
29]. In this case, other diagnoses should be ruled out, such
as intra-hepatic cholangiocarcinoma, epithelioid haema-
ngioendothelioma or, more rarely, metastases with a
fibrotic component. Pedunculated haemangiomas are rare
and, in general, its signal intensity and enhancement
pattern is consistent with the diagnosis (Fig. 5b), except if
they undergo torsion and infarction, when they can become
symptomatic. Recognition of its hepatic origin is better
accomplished using multiplanar images, allowing identifi-
cation of the stalk [7, 30]. Sometimes, bile duct dilatation
may occur because of large haemangiomas centrally
located within the liver, especially around segment IV
and near the liver hilum (Fig. 6). Therefore, this feature
should not preclude the diagnosis [7, 30, 31].
Calcifications in haemangiomas can be found with a
central or peripheral location, with multiple foci usually
representing phlebolites. They are better depicted on CT as
tiny dense nodules or as low signal intensity foci within the
hyperintense tumour on T2-w images [7] (Fig. 7). MRI is
useful for identifying intra-tumoural haemorrhage, dis-
playing areas with high signal on T1-w images, best
depicted on fat-supression sequences (Fig. 8a,b). Blood
signal intensity on T2-w images is variable, depending on
the products of haemoglobin degradation. The spared non-
haemorrhagic areas of the lesion usually maintain the same
signal intensity and enhancement pattern of typical
haemangiomas [7]. Intra-peritoneal bleeding is exceed-
ingly rare but may be associated even with minor
Fig. 10 a, bHypodynamic haemangiomawith a late-filling pattern on
MRI. a Plain T2-w image showing high signal intensity and
homogeneous pattern. b Dynamic imaging showing peripheral
enhancement on the portal phase of the dynamic study. Thirty minutes
after contrast injection, the fill-in pattern and persistent enhancement
were seen (not shown), thus, enabling the correct diagnosis
Fig. 11 a, b Hyperdynamic
haemangiomas seen on dynamic
CT associated with an arterio-
portal fistula. a Plain image
disclosing four hypodense focal
lesions at the right liver lobe. b
The arterial phase of the dy-
namic CT study reveals two
haemangiomas with the usual
flow pattern and two other
flash-filling, causing adjacent
perfusion abnormalities. Early
opacification of a segmental
branch of the portal vein (arrow
in b) can be recognised due to
an associated arterio-portal fis-
tula. An incidental liver cyst is
seen at segment IV
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abdominal trauma in cases of large superficial tumours.
Cystic and multilocular haemangiomas containing a large
central cavity are extremely rare. On MRI, this atypical
feature is represented by a single or multiple intra-tumoural
cavities, possessing long T1 and T2 relaxation times related
to thrombosis and old haemorrhage. Nevertheless, periph-
eral enhancement with puddling can still occur [7]. In rare
instances, a fluid–fluid level may be depicted inside the
haemangioma, which is thought to represent stagnant or
slow flowing blood with sedimentation of red blood cells
on the dependent portion [32]. The superior fluid layer
consists of serum and the inferior layer contains unclotted
sedimentary red blood cells [7, 32]. On CT, the superior
layer shows fluid attenuation, while the inferior layer has
higher attenuation due to the density of the packed cells.
On MRI, T2-w sequences show high signal intensity on the
upper layer and a less intense signal on the more cellular
inferior layer (Fig. 8c). The fluid–fluid level is not specific
of haemangiomas and has been reported in other lesions,
such as complicated cysts, ciliated foregut cysts, chronic
haematomas, biliary cystadenomas, tumours with lique-
factive necrosis or haemorrhage, and necrotic metastases
[33]. In general, histopathologic correlation is necessary to
confidently establish the diagnosis [7, 32–34].
Interval growth has been reported in haemangiomas,
although it is extremely rare. In this situation, the initial
diagnosis should be questioned and biopsy studies
performed on selected cases [9].
Uncommon enhancement patterns
The current use of state-of-the-art CT and MRI equipment
with high temporal resolution increasingly reveals less
known enhancing patterns of haemangiomas. The so-called
flash-filling pattern is mostly seen in small tumours under
Fig. 12 a, b Other atypical
enhancement patterns of
haemangiomas seen on CT.
a Arterial phase image of a
dynamic CT study showing a
triangular hyperdense area
representing arterio-venous
shunting. This area corresponds
to a transient hepatic
attenuation differences (THAD)
that was no longer depicted in
the portal venous phase (not
shown). b Haemangioma show-
ing an area of central
enhancement
Fig. 13 a, b Sclerosed haemangioma. a Low-power magnification
haematoxylin and eosin (H&E) staining showing complete obliter-
ation of the vascular channels and replacement by fibrous tissue. b
Corresponding heavily T2-w image disclosing loss of the typical
light bulb intensity of the haemangioma (compare with the CSF
signal)
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2 cm and show fast, intense and uniform enhancement on
the arterial phase of the dynamic study, typically,
paralleling aortic enhancement (Fig. 9) [35, 36]. Since
these tumours may also display colour spots on Doppler
examination, differentiation from other hypervascular
tumours may be problematic. A key point resides on the
evaluation of the late interstitial phase of the dynamic
study, where flash-filling haemangiomas should not reveal
contrast washout. In contrast to haemangiomas with this
type of hyperdynamic status, on the other side of the
spectrum, hypodynamic tumours with very slow internal
flow may be seen, resulting in a very delayed fill-in pattern.
These cases request prolonged examination times with
ultra-delayed acquisitions, in order to be able to observe the
centripetal enhancement and contrast retention within the
tumour (Fig. 10). These haemodynamic differences are
probably related to the size of the vascular channels
composing the haemangioma, with slow flow in areas of
large channels and hyperdynamic flow in those containing
small-sized channels.
Peri-lesional enhancement is seen in 19–25% of cases
and manifests itself as transient hepatic attenuation differ-
ences (THAD), corresponding to staining areas seen on the
arterial phase of liver enhancement, fading away on the
subsequent phases of the dynamic study [36, 37]. Patho-
logical explanation resides in arterio-venous shunting
related to their hyperdynamic status. Early opacification
of a drainage vein may occur (Fig. 11) [36, 38]. Although
THAD is mostly seen in cases of small flash-filling
haemangiomas, larger tumours can also show the same
perfusion abnormalities due to portal vein compression and
compensatory arterial inflow, determining a peri-tumoural
area of parenchymal enhancement [36] (Fig. 12a). It must
be stressed that peri-lesional THADs have been described
in association with a variety of focal liver lesions, such as
metastases, abscesses and hepatocellular carcinoma [38].
Haemangiomas presenting an early central enhancement
evolving centrifugally are rare (Fig. 12b). According to
Kim et al. [13], these lesions have a central area with
multiple vascular spaces and peripheral regions with a
dominant fibrous component. More frequently, central
enhancement is simulated by the axial nature of the CT
slices.
Hyalinised or sclerosed haemangioma is rather
unusual and is believed to represent the end stage of a
haemangioma involution. The replacement of the vascular
spaces by hyalinised fibrotic tissue leads to marked
modifications of its imaging features, with loss of the
typical globular enhancement on contrast-enhanced studies
and of its high signal intensity on T2-w images on MRI
(Fig. 13). Since it is virtually impossible to propose a
definitive diagnosis in such a case, pathologic proof may be
necessary, which discloses extensive fibrotic tissue and
obliteration of the vascular channels. Differential diagnosis
should include hypovascular tumours, especially metasta-
ses [7, 39].
Fig. 14 Haemangioma and as-
sociated liver abnormalities.
a, b Haemangioma in fatty liver.
a Plain CT image disclosing a
low liver density consistent
with diffuse steatosis. The
haemangioma is practically
invisible. b After contrast
enhancement, the haemangioma
is disclosed with the typical
peripheral globular enhance-
ment. c, d Association of focal
nodular hyperplasia (FNH) and
haemangioma. c Arterial phase
of a dynamic MRI depicting the
vigorous enhancement of an
FNH at the left liver lobe
and the peripheral puddling of
contrast in the small
haemangioma at segment VII.
d Portal venous phase of the
same case on CT showing
contrast retention within the
haemangioma and a near-
isodensity of the left lobe FNH
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Associated liver abnormalities
Haemangioma in fatty liver may be difficult to diagnose on
US and CT, due to the decreased liver–lesion contrast
which, in severe steatosis, may even be reversed in both
imaging modalities, with the haemangioma being hypo-
echoic and denser, respectively, when compared to the
adjacent fatty liver (Fig. 14a,b). Although dynamic CT is
able to show the characteristic enhancement pattern, MRI
may be preferable in this setting, especially using in-phase
and out-of-phase gradient-echo sequences. The high signal
intensity on T2-w images and the enhancement features are
preserved, thus, rendering the diagnosis relatively straight-
forward. Sometimes, in CT studies, a peripheral dense halo
may be seen surrounding the haemangioma. This corre-
sponds to spared non-fatty parenchyma, as a consequence
of the preferential arterial inflow and/or decreased portal
flow around the lesion due to compression phenomena [12].
Haemangioma in cirrhotic liver is rare, with an
incidence estimated to be about 1.7% at pathologic
examination and 0.6% at CT, which is clearly lower
than the frequency in unselected autopsy series or at CT
in non-cirrhotic patients [40, 41]. Despite the stiffening
of the liver parenchyma, haemangiomas generally retain
their characteristic findings, both on T2-w images and
the enhancement pattern. In rare cases, however, mostly
in advanced cirrhosis, they can lose their typical
imaging features due to the development of fibrosis,
determining lower volume and lower signal intensity on
T2-w images [12, 40, 42]. MRI seems to be superior to
CT for characterising haemangiomas in cirrhosis, due to
its intrinsic higher contrast resolution and the additional
information conveyed by the T2-w sequences, which
can also incorporate quantitative data as T2 relaxation
value calculation and/or performance of sequences using
very late echo times [40].
Haemangioma associated with focal nodular hyperpla-
sia (FNH) (Fig. 14c,d) has been reported in approximately
20% of cases of patients having a concomitant FNH, a
prevalence that is higher than that observed in the general
population. A common physiopathological mechanism
may explain this association, which is believed to result
from a focal disturbance of the liver blood supply
facilitating a hyperplastic response and subsequent devel-
opment of these benign tumours [43, 44].
In conclusion, liver haemangiomas have specific
imaging features, allowing its characterisation with
cross-sectional imaging techniques. There is, however, a
wide range of findings that fall out of the typical
description, which are, essentially, due to modifications
of the tumour structure or flow dynamics. Current state-
of-the-art imaging techniques are more prone to demon-
strating these findings, thus, increasing their diagnostic
confidence level.
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